NABP has launched an initiative to transfer prescription monitoring program information across state lines
Five men, five different careers: all driven by a common passion for pharmacy
The time has come for pharmacists to work on reforming the maximum allowable costs put forth by the pharmacy benefit managers
Watch out for pharmacists who have had enough: They can find some imaginative ways of registering their dissatisfaction
The industry should collaborate to develop a U.S. Biopharmacopeia Registry of Biopharmaceutical Products to help resolve biosimilar and broader biopharmaceutical nomenclature issues, according to a leading author and publisher.
The Obama administration?s plan to close the racial and ethnic gap on childhood asthma has drawn strong support from the Merck Childhood Asthma Network.
How much sense does it make to put employees of major drug chains on state Boards of Pharmacy? Depends on whose chickens that fox is guarding.
As pharmacists and others wait to learn ACA's fate in the U.S. Supreme Court, the issue of provider status under the Social Security Act continues to worry those seeking to expand into MTM and other clinical services.
Healthcare industry experts discuss the pros and cons.
One pharmacist argues that wanting to be called Doctor is more than just ego.